Starch Medical Inc. of San Jose, CA at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Starch Medical Inc.

2150 Ringwood Ave., 95131 San Jose, CA
USA
Telephone +40 95131 84289818
Fax +40 95131 84289818
info@starchmedical.com

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2018 hall map (Hall 16): stand E32-1

Fairground map

MEDICA 2018 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.03  Surgery devices, endoscopy devices
  • 01.03.12  Other surgical instruments and products

Other surgical instruments and products

Our products

Product category: Other surgical instruments and products

SealFoam®

SealFoam® Absorbable Polysaccharide Hemostat is a medical device composed of AMP® (absorbable modified polymer) particles which are very hydrophilic, biocompatible, non-pyrogenic and derived from purified plant starch.The device contains no human or animal components. SealFoam is a naturally adhesive absorbable hemostatic pad designed to control bleeding during surgical procedures or following traumatic injuries. SealFoam may be trimmed to address specific procedural requirements and is indicated for a diverse range of applications and unique wound contours. SealFoam is absorbed in the body within a few days or may be irrigated prior to closure

Features
  • 100% Plant-Based
  • Fast Hemostasis
  • Rapid Absorption in the Body
  • Naturally Adhesive – Easy to Apply
  • Non-pyrogenic, Latex Free
 
 
Clinical Benefits
  • Effectively controls oozing and bleeding
  • Eliminates the risks associated with
  • human/animal-derived hemostats
  • Protect sternum by forming a gel barrier
  • Does not interfere with hone healing process
  • Minimizes the occurrence of re-bleeding

More Less

About us

Company details

Starch Medical Inc. (SMI) is a San Jose, California based medical device company engaged in the design, manufacture and sale of innovative, absorbable hemostatic products. Our mission is to deliver advanced hemostatic technologies in a safe and effective manner to reduce bleeding-associated risks in surgeries and trauma.

SMI is committed to becoming an industry leader in surgical hemostats, providing surgeons a safe option for a diverse range of surgeries. The proprietary AMP® technology platform consists of biocompatible, ultra-hydrophilic polymer particles synthesized from purified plant starch. AMP® particles contain no human or animal components.
At SMI, we are dedicated to hemostatic excellence. This performance is reflected in our goal to provide customized systems to further improve the delivery of our break through AMP® technology. SMI is committed to supply the medical community with the most advanced and reliable hemostatic products.

Hemostasis Technology
AMP® is the Absorbable Modified Polymers technology platform that consists of biocompatible, ultra-hydrophilic and adhesive polymer particles synthesized from purified plant starch to control bleeding. AMP® materials contain no human or animal components. SuperClot®, PerClot®, SealFoam® and Responder® all incorporate the AMP® technology.
AMP® particles have a molecular structure that rapidly absorbs water from blood, causing a high concentration of platelets, red blood cells and coagulation proteins at the bleeding site, accelerating the physiologic clotting cascade. The interaction of AMP® with blood rapidly produces a gelled matrix that adheres to and seals the bleeding tissue. AMP® particles are readily dissolved by saline irrigation and are degraded rapidly by human enzymes, primarily amylase, within a few days.
SuperClot®, PerClot®, SealFoam® and Responder® patents are granted in the United States, Europe, Japan, India and China.
SuperClot®, SealFoam® and Responder® are not approved for distribution in the United States.

More Less